Document Type

Article

Publication Date

3-2016

Abstract

In lieu of an abstract, here is the article's first paragraph:

Formulation scientists are constantly challenged with unique opportunities to deliver chemotherapeutic drug molecules to cancer patients. With the growing rate of cancer diagnoses, new therapies are being introduced to pave their way to the market. Along with drug delivery, these formulation approaches are being screened for formulation, design, and development of cancer vaccines. Can a vaccine be formulated to obtain a protective or therapeutic immune response against cancer?

Comments

Reprinted from the March 2016 issue of AAPS Newsmagazine. © 2016 American Association of Pharmaceutical Scientists. All rights reserved. Reprinted with permission. Not for further use without written permission.

AAPS Newsmagazine Online: http://www.aapsnewsmagazine.org/

Share

COinS